BioSpace News Archive

Press Releases

Halia Therapeutics’ CEO, Dr. David J. Bearss, to Present Groundbreaking Research on Chronic Inflammation and Aging at the 3rd Edition Global Longevity Federation

August 7, 2024

·

3 min read

Press Releases

NeuroTherapia Raises $12.3M in the First Close of its Series B Financing

August 7, 2024

·

4 min read

Press Releases

OS Therapies Announces Osteosarcoma Scientific and Medical Advisory Board

August 7, 2024

·

5 min read

Policy

As Election Nears, Pharma Hedges Campaign Contribution Bets

Lobbying groups and individuals connected with the industry are supporting candidates from both parties, with a particular focus on the future of the 340B discount program and pharmacy benefit managers.

August 7, 2024

·

4 min read

·

Tyler Patchen

Deals

Top I&I Deals So Far in 2024

The size of the global immunology market is projected to nearly double by 2032 to a quarter of a trillion dollars. Here are this year’s standout deals in the space.

August 7, 2024

·

5 min read

·

Mollie Barnes

Rare Diseases

Biopharma Entrepreneurs Make Business Case for Personalized Genetic Medicines

Experts say the time is now to develop and provide widespread access to genetic medicines for the rarest diseases. What’s more, they say it is a moral imperative.

August 7, 2024

·

6 min read

·

Heather McKenzie

Press Releases

Aquestive Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update

August 7, 2024

·

34 min read

Press Releases

Globus Medical Reports Second Quarter 2024 Results